title: [Cefoxitin: its role in the therapy of anaerobic infections].
abstract: Cefoxitin is a second generation cephalosporin commonly used to treat anaerobic and mixed infections. The authors reviewed the recently published data about the efficacy of cefoxitin; its utility in different clinical entities, patterns of resistance and resistance mechanisms, indications and reliability of in vitro susceptibility testing. These data indicate the need for determining susceptibility patterns of anaerobics at each hospital and point out to the essential close communication between the microbiologist and clinician to the rational treatment of anaerobic infections.
authors.affiliation: Serviço de Medicina, Hospital de S. Francisco Xavier, Lisboa.
authors.forename: A
authors.initials: A
authors.lastname: Carvalho
authors.forename: C
authors.initials: C
authors.lastname: Fonseca
authors.forename: F
authors.initials: F
authors.lastname: Falcão
authors.forename: F
authors.initials: F
authors.lastname: Ceia
mesh_terms: D001421:Bacteria, Anaerobic / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D002440:Cefoxitin / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D008826:Microbial Sensitivity Tests
chemical_list: D002440:Cefoxitin
vernacular_title: Cefoxitina: papel na terapêutica das infecções por anaeróbios.